UnitedHealth Group Inc (NYSE:UNH) Shares Bought by Capital Bank & Trust Co
Capital Bank & Trust Co lifted its position in UnitedHealth Group Inc (NYSE:UNH) by 1.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 565,438 shares of the healthcare conglomerate’s stock after purchasing an additional 8,471 shares during the quarter. UnitedHealth Group makes up 2.2% of Capital Bank & Trust Co’s investment portfolio, making the stock its 7th biggest holding. Capital Bank & Trust Co owned about 0.06% of UnitedHealth Group worth $166,227,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Capital City Trust Co. FL lifted its position in UnitedHealth Group by 1.1% during the fourth quarter. Capital City Trust Co. FL now owns 3,557 shares of the healthcare conglomerate’s stock worth $1,046,000 after buying an additional 38 shares during the period. Moloney Securities Asset Management LLC grew its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Moloney Securities Asset Management LLC now owns 10,133 shares of the healthcare conglomerate’s stock valued at $2,979,000 after purchasing an additional 38 shares in the last quarter. Cypress Capital Group grew its stake in UnitedHealth Group by 0.5% in the fourth quarter. Cypress Capital Group now owns 7,154 shares of the healthcare conglomerate’s stock worth $2,103,000 after purchasing an additional 39 shares in the last quarter. Clear Harbor Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 0.6% in the 4th quarter. Clear Harbor Asset Management LLC now owns 6,613 shares of the healthcare conglomerate’s stock valued at $1,944,000 after buying an additional 40 shares during the period. Finally, Adviser Investments LLC grew its position in UnitedHealth Group by 2.1% in the 4th quarter. Adviser Investments LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $570,000 after purchasing an additional 40 shares during the last quarter. 88.16% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have recently weighed in on UNH shares. Stephens lifted their price target on UnitedHealth Group from $325.00 to $333.00 and gave the company an “overweight” rating in a report on Wednesday, January 15th. Citigroup reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, March 4th. Piper Jaffray Companies increased their target price on shares of UnitedHealth Group from $312.00 to $325.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 4th. SunTrust Banks boosted their price target on shares of UnitedHealth Group from $335.00 to $350.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. Finally, Raymond James upped their price target on shares of UnitedHealth Group from $300.00 to $320.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Four analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $315.55.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.77 by $0.13. The firm had revenue of $60.90 billion during the quarter, compared to analyst estimates of $61.17 billion. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $3.28 EPS. Research analysts forecast that UnitedHealth Group Inc will post 16.47 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Stockholders of record on Monday, March 16th were paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date was Friday, March 13th. UnitedHealth Group’s payout ratio is 28.59%.
In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of $299.45, for a total value of $4,491,750.00. Following the transaction, the director now directly owns 158,598 shares in the company, valued at $47,492,171.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $237.00, for a total value of $1,185,000.00. Following the completion of the transaction, the director now owns 1,406,500 shares in the company, valued at $333,340,500. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,000 shares of company stock valued at $12,081,050. 0.87% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Why is a lock-up period needed for an IPO?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.